This group is the default community for every Energy Central registered member. We discuss and share a variety of topics related to the global power industry. 


Phase 3 COVID-19 Vaccines – Rev a

image credit:
John Benson's picture
Senior Consultant, Microgrid Labs

PROFESSIONAL EXPERIENCE: Microgrid Labs, Inc. Advisor: 2014 to Present Developed product plans, conceptual and preliminary designs for projects, performed industry surveys and developed...

  • Member since 2013
  • 886 items added with 598,423 views
  • Sep 10, 2020

Access Publication

It is very difficult for utility business leaders to plan future projects and resource allocations when they do not know when the COVID-19 Pandemic will end. Currently it seems to be getting worse every day.

Utilities are losing revenue because of the inability of many of their residential and small commercial accounts to pay. Many states, counties and municipalities have put moratoriums on power shutoffs, and many small businesses have simply shut down,

In addition COVID-19 has forced all utilities to drastically modify their operations to avoid infecting their employees and the public they serve. It was already difficult to maintain staffing levels, and the loss of even a few employees due to sickness or worse will increase pressure on key skills. Record heat waves and a hurricane season with above normal number storms stretch resources even more. Also, we are a couple of months away from flu season in the U.S.

To make matters more critical, as I write this significant wildfires have been raging throughout the west. This has already been a record wildfire season for California, and the wildfires normally peak in October. Crews must be sent into areas devastated by wildfires and those impacted by public safety power shutoffs.

The only future good news will be when a COVID-19 Vaccine is available in millions of doses.

What the original post of this document did was define firms and partnerships that had entered Phase 3 trials for their COVID-19 vaccines as its posting date (July 31). In this post I will describe progress by those developers, and additional developers that will likely offer vaccines in the U.S. in large volumes before the end of 2020 or early 2021.


No discussions yet. Start a discussion below.

John Benson's picture
Thank John for the Post!
Energy Central contributors share their experience and insights for the benefit of other Members (like you). Please show them your appreciation by leaving a comment, 'liking' this post, or following this Member.
More posts from this member

Get Published - Build a Following

The Energy Central Power Industry Network is based on one core idea - power industry professionals helping each other and advancing the industry by sharing and learning from each other.

If you have an experience or insight to share or have learned something from a conference or seminar, your peers and colleagues on Energy Central want to hear about it. It's also easy to share a link to an article you've liked or an industry resource that you think would be helpful.

                 Learn more about posting on Energy Central »